News | Quality Assurance (QA) | September 16, 2019

Sun Nuclear Presents Portfolio of Independent Radiotherapy QA Solutions at ASTRO 2019

Company will highlight new tools for workflow automation and emergent techniques

Sun Nuclear Presents Portfolio of Independent Radiotherapy QA Solutions at ASTRO 2019

The PlanCheck module now part of SunCheck, automates plan quality checks, validates treatment plans against requirements, and automatically assesses plan performance versus intent.

September 16, 2019 — At the 2019 American Society for Radiation Oncology (ASTRO) Annual Meeting, running Sept. 15-18 in Chicago, Sun Nuclear Corp. will present novel advancements in radiation oncology quality management.

For the SunCheck Quality Management Platform, Sun Nuclear introduces PlanCheck. This new module within the SunCheck Patient workflow automates plan quality checks, validates treatment plans against requirements, and automatically assesses plan performance versus intent. At ASTRO 2019, Sun Nuclear will also highlight SunCheck's expanded direct device integration, plus support for Varian Halcyon System secondary dose calculations, pre-treatment quality assurance (QA) and in-vivo monitoring.

Sun Nuclear will also introduce new Precision Laser Systems for positron emission tomography/computed tomography (PET/CT) simulation, magnetic resonance (MR) simulation, MR-guided radiotherapy (RT) and linear accelerator (linac)-based RT. Redesigned to better fit clinical workflows, CT SIM+ and MICRO+ laser systems offer high precision and accuracy at the patient, with what the company calls unmatched reliability, laser line definition and laser line length. Compatible with all major third-party systems, CT SIM+ software provides automation for enhanced patient focus.  

Beyond workflow automation support, Sun Nuclear enables adoption of emergent treatment techniques, including stereotactic radiosurgery (SRS) and MR-guided radiation therapy (MRgRT).

Enhancing the Sun Nuclear SRS QA portfolio is the introduction of the MultiMet-WL Cube. The device quantifies the margin of error for off-axis SRS targets, measuring error margins for single-isocenter multiple metastases treatments. Further supporting SRS programs are advancements with SRS MapCheck, including support for the Accuray CyberKnife System and vertex fields, including HyperArc. 

Sun Nuclear addresses the challenges of MRgRT with a suite of solutions, including ArcCheck-MR and IC Profiler-MR. Available soon and on display at ASTRO, Daily QA-MR will become the first commercially available daily QA system for MR-linacs.

For more information: www.sunnuclear.com

Related Content

Videos | Radiation Oncology | October 11, 2019
Lorraine Drapek, DNP, nurse practitioner, radiation oncology, GI service,...
Patient Treatments With ViewRay's MRIdian Linac Begin in New England
News | Image Guided Radiation Therapy (IGRT) | October 08, 2019
ViewRay Inc. announced today that patient treatments are scheduled to begin in Boston with ViewRay's MRIdian Linac...
ProTom International received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Radiance 330 proton therapy system
News | Proton Therapy | October 07, 2019
ProTom International received 510(k) clearance from the U.S.
Attendees of ASTRO 2019 walked the halls of McCormick Place in Chicago, Ill.

Attendees of ASTRO 2019 walked the halls of McCormick Place in Chicago, Ill.

Feature | ASTRO | October 03, 2019 | By Greg Freiherr
At the American Society for Radiation Oncology’s (ASTRO) 2019 a
Videos | Prostate Cancer | September 30, 2019
Bill Hartsell, M.D., medical director of the Northwestern Medicine Proton Center in Warrenville, Ill., discusses the
eBook on Hypofractionation in the Age of Value-based Care

eBook on Hypofractionation in the Age of Value-based Care

Sponsored Content | Case Study | Radiation Therapy | September 30, 2019
Hypofractionated and ultrahypofractionated radiation therapy — increasing dose per fraction to enable significantly f
AI Accurately Predicts Radiotherapy Side Effects for Head and Neck Cancer Patients
News | Artificial Intelligence | September 26, 2019
For the first time, a sophisticated computer model has been shown to accurately predict two of the most challenging...